Medical imaging tools like digital mammography, 3D mammography, and chest CT scans are important for finding and diagnosing cancer. But looking at thousands of images from each patient can be hard. Radiologists sometimes miss small signs of cancer between checkups, called interval cancers. These signs can be faint and tough to spot.
AI technology in medical imaging helps find cancers better and lowers mistakes by humans. A study at UCLA led by Dr. Tiffany Yu showed that AI software called Transpara cut interval breast cancer rates by almost 30%. Transpara looks at mammograms and rates them by cancer risk. It acts like a “second set of eyes” for the doctors. The AI found 76% of mammograms first read as normal but later linked to interval cancers. Also, 90% of the missed cases, where doctors missed cancer signs, were flagged by AI. This helps catch cancers earlier.
This shows how AI can help radiologists spot faint problems and avoid missed cancers. But the study also said AI had trouble showing the exact spot of hidden cancers, marking only 22% of tumor locations correctly. This means AI should help doctors, not replace them.
For lung cancer, early detection is very important because survival chances rise a lot when found early. But only about 4% of people who should get lung cancer screening actually do it. Dr. Sangita Kapur from the University of Cincinnati Cancer Center said AI software like ClearRead improves finding lung nodules. ClearRead works like a second reader, removing normal body details to make suspicious spots easier to see.
Using ClearRead made doctors better at finding lung nodules, increasing detection from 64.5% to 80%. It also reduced the time to read scans by 26%. The software can find nodules as small as 5mm and measure their size and type. This helps doctors work faster and more accurately. With better detection, early lung cancer diagnoses went up by 30%, increasing chances for cure. Dr. Kapur says AI helps doctors, not replaces them, keeping decisions in skilled hands.
Medical practice leaders and IT teams need to know the real benefits of AI when thinking about using it in cancer diagnosis and patient care.
AI systems often find very slight problems in images that humans may miss, especially when tired or busy. For example, AI in mammograms finds very early cancer signs and cuts down missed cases. AI also makes lung cancer nodules stand out clearly, helping catch cancer when it can be treated best.
AI tools can shorten the time doctors spend looking at scans. ClearRead makes reading scans over 25% faster. With this, more people can get screened and diagnosed each day. This is important because there are not enough radiologists in some areas. AI also removes extra body details from images, so doctors can focus better on possible problems.
AI in imaging now often works with data about the patient’s history to create better screening and treatment plans. This is called predictive preventive care. It helps find people at higher risk early and changes checkup schedules based on each person’s risk, instead of having a one-size-fits-all plan.
Apart from reading images, AI automation helps medical practices work better day to day. It can take care of routine paperwork and clinical records, so healthcare workers can spend more time on patients. This also lowers mistakes from manual data entry.
New AI tools use technologies like Generative AI and Natural Language Processing to handle reports. AI can check imaging reports and create summaries, helping reduce the workload for doctors and staff. This speeds up how fast reports are ready and keeps documents consistent for billing and rules.
AI scheduling systems can organize appointments based on how urgent they are, patient risk, and available staff. This way, high-risk patients get timely checkups without delays. Automated reminders also help patients keep up with their screening schedules. This is important since lung cancer screening rates are still low in many parts of the country.
AI tools that work smoothly with EHR systems can support better clinical decisions. They can alert doctors right away about any abnormalities found or remind them when patients need extra screenings based on history. Good AI and EHR connection also cuts down repeating tasks and entering data by hand.
Automating insurance claims and billing processes can make payment faster. This matters because cancer screening may involve complicated billing with genetic tests and treatments covered by different insurance plans.
AI shows promise in helping find cancer early, but medical leaders must handle some challenges to make it work well.
Dealing with sensitive patient data needs strong cybersecurity. AI models need large amounts of data, so it is important to follow HIPAA rules and use safe data storage. Practices using cloud-based AI should carefully check risks and make sure vendors are responsible.
Healthcare workers must be trained to use AI tools well. They need to understand AI results and keep making good clinical decisions. Without proper training, AI won’t work as well and could cause problems in daily work.
Adding AI systems to current radiology machines and EHRs can be hard and expensive. Leaders should weigh costs and benefits and start with AI tools that have the biggest impact, like those for lung or breast cancer screening.
Rules for AI in healthcare keep changing. Practices need to watch FDA approvals, follow ethics, and keep up with data rules to avoid problems with biased AI or bad use of data.
The AI market in U.S. healthcare is expected to grow a lot. Experts say it could reach nearly $187 billion by 2030, up from $11 billion in 2021. A 2025 survey by the American Medical Association found 66% of U.S. doctors use health AI tools. This is up from 38% in 2023. Also, 68% of doctors reported AI helps patient care, showing that more doctors accept AI.
New AI tools keep improving early disease detection. Some devices, like AI-powered stethoscopes, can diagnose heart problems in seconds. This shows that AI helps in medical tests beyond imaging.
Using AI in medical imaging for cancer screening helps find cancer earlier and improves patient results. Tools like Transpara for breast cancer and ClearRead for lung CT scans have improved detection rates and made work faster. These tools support radiologists by highlighting missed or faint findings and lowering reading time.
AI also automates documentation, scheduling, and billing, cutting down paperwork and improving practice operations. But using AI well means investing in secure IT systems, training staff, and following ethical and legal rules.
Medical leaders in the U.S. should think about adding AI in steps that fit their practice’s needs, patient risks, and resources. This approach can help practices better cancer screening, work more efficiently, and give better care through new technology.
By looking carefully at AI’s advantages along with challenges, medical practices can start using AI in cancer screening to find cancer earlier, ease clinical staff work, and improve health results for their communities.
The Ministry of Health highlights genomics, artificial intelligence (AI), and a focus on preventive care as the three major developments driving healthcare transformation.
MOH is applying AI by supporting innovations in public healthcare institutions, scaling proven AI use cases system-wide such as Generative AI for routine documentation and AI for imaging to enhance efficiency and patient outcomes.
Generative AI is being used to automate repetitive tasks like medical record documentation and summarisation, freeing healthcare professionals to focus more on patient care, with rollout planned before end 2025.
AI models support earlier detection and faster follow-up of clinically significant signs; for example, AI is being studied to improve breast cancer screening workflows and is accessed via the AimSG platform across public hospitals.
MOH is launching a national FH genetic testing programme by mid-2025 to identify and manage patients with high cholesterol genetic risk early, involving subsidised testing, family screening, and lifestyle and therapy support to reduce cardiovascular risk.
MOH stores healthcare data on secured cloud platforms managed by GovTech and Synapxe, restricts internet access for healthcare staff, and uses the TRUST platform that anonymises datasets for research, preventing data downloads and ensuring deletion after analysis.
HEALIX, a cloud-based data infrastructure developed with Synapxe, enables secure sharing of anonymised clinical, socio-economic, lifestyle, and genomic data across healthcare clusters to develop, train, and deploy AI models for clinical and operational use.
MOH has implemented a moratorium disallowing genetic test results for insurance underwriting and is working on legislation to govern genetic data use, aiming to prevent discrimination in insurance and employment through broad consultations and upcoming laws.
MOH will identify proven AI use cases and centrally scale them into national projects, beginning with Generative AI for documentation and imaging AI, supported by platforms like AimSG and HEALIX to ensure accuracy, safety, and system-wide integration.
Following FH, MOH plans to expand predictive preventive care to diseases like breast and colon cancers, diabetes, kidney failure, stroke, and heart attacks using sophisticated multivariate AI models for early detection and intervention.